OpenAlex
PricingAboutJobs
Log inGet started
Work

Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer

HTML

Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2005.23.16_suppl.564
Authors: J. T. Carpenter, H. Roché, M. Campone, R. Colomer, A. Jagiello-Gruszfeld, L. Moore, M. D’Amore, S. Kong, J. Boni, J. Baselga
Institutions: University of Alabama at Birmingham, Institut Català d'Oncologia, Institut Claudius Regaud, Wyeth
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: temsirolimus, letrozole, mTOR inhibitors, metastatic breast cancer, locally advanced breast cancer, postmenopausal women, combination therapy, intermittent dosing, drug toxicity, hyperglycemia, objective response rate, treatment safety, endocrine therapy, PI3K/AKT/mTOR pathway, PI3K inhibitors, HER2-negative breast cancer, hormone receptor-positive breast cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2243880667
Cites:
Cited by: 100
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security